Cargando…

LncRNA CCAT1 enhances chemoresistance in hepatocellular carcinoma by targeting QKI-5

A major reason for treatment failure of cancer is acquisition of drug resistance. The specific mechanisms underlying hepatocellular carcinoma (HCC) chemoresistance need to be fully elucidated. lncRNAs involve in drug resistance in some cancers, however, the exact functions of lncRNA colon cancer-ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Chongsheng, Sun, Yurui, Li, Yang, Ma, Junli, Shi, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098857/ https://www.ncbi.nlm.nih.gov/pubmed/35552451 http://dx.doi.org/10.1038/s41598-022-11644-4

Ejemplares similares

Association of lncRNA CCAT2 and CASC8 Gene Polymorphisms with Hepatocellular Carcinoma
por: Wu, Edie-Rosmin, et al.
Publicado: (2019)

Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells
por: Yang, Chun, et al.
Publicado: (2019)

LncRNA CCAT2 promoted osteosarcoma cell proliferation and invasion
por: Yan, Lihua, et al.
Publicado: (2018)

LncRNA CCAT1 is overexpressed in tuberculosis patients and predicts their survival
por: Ye, Taosheng, et al.
Publicado: (2021)

lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion
por: Zhang, Caixiang, et al.
Publicado: (2019)

CCAT2 enhances autophagy‐related invasion and metastasis via regulating miR‐4496 and ELAVL1 in hepatocellular carcinoma
por: Shi, Jing, et al.
Publicado: (2021)

LncRNA CCAT1 functions as apoptosis inhibitor in podocytes via autophagy inhibition
por: Su, Yanyan, et al.
Publicado: (2019)

LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement
por: Zhang, Cong, et al.
Publicado: (2023)

LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR‐9‐5p/QKI‐5 axis
por: Wu, Meng, et al.
Publicado: (2018)

CRISPR/Cas9 Knockout Strategies to Ablate CCAT1 lncRNA Gene in Cancer Cells
por: Zare, Khadijeh, et al.
Publicado: (2018)

lncRNA CCAT2 Enhanced Resistance of Glioma Cells Against Chemodrugs by Disturbing the Normal Function of miR-424
por: Ding, Jun, et al.
Publicado: (2020)

The Reciprocal Interaction Between LncRNA CCAT1 and miR-375-3p Contribute to the Downregulation of IRF5 Gene Expression by Solasonine in HepG2 Human Hepatocellular Carcinoma Cells
por: Liu, Zheng, et al.
Publicado: (2019)

Clinical value of lncRNA CCAT1 in serum extracellular vesicles as a potential biomarker for gastric cancer
por: Xiao, Ke, et al.
Publicado: (2021)

LncRNA CCAT1 facilitates the proliferation, invasion and migration of human laryngeal squamous cell carcinoma cells via the miR-218-5p/BMI1
por: Hong, Jing, et al.
Publicado: (2022)

The lncRNA CCAT1 Upregulates Proliferation and Invasion in Melanoma Cells via Suppressing miR-33a
por: Lv, Li, et al.
Publicado: (2018)

Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA
por: Ahmadpour, Seyedeh Tayebeh, et al.
Publicado: (2023)

LncRNA PRNCR1 rs1456315 and CCAT2 rs6983267 Polymorphisms on 8q24 Associated with Lung Cancer
por: Yu, Wei-Ling, et al.
Publicado: (2021)

Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19
por: Ren, Jing, et al.
Publicado: (2018)

LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular carcinoma
por: Xie, Shu-Cai, et al.
Publicado: (2020)

LncRNA HCG11/miR‐26b‐5p/QKI5 feedback loop reversed high glucose‐induced proliferation and angiogenesis inhibition of HUVECs
por: Du, Jiao, et al.
Publicado: (2020)

Knockdown of lncRNA CCAT1 Inhibits the Progression of Colorectal Cancer via hsa-miR-4679 Mediating the Downregulation of GNG10
por: Wang, Ning, et al.
Publicado: (2021)

Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1
por: Li, Xiaohui, et al.
Publicado: (2020)

LncRNA PTPRG-AS1 Promotes the Metastasis of Hepatocellular Carcinoma by Enhancing YWHAG
por: Chen, Gaoyang, et al.
Publicado: (2021)

LncRNA CCAT1 Promotes Colorectal Cancer Tumorigenesis Via A miR-181b-5p/TUSC3 Axis
por: Chen, Si, et al.
Publicado: (2019)

Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus
por: Xiang, Jian-Feng, et al.
Publicado: (2014)

The lncRNA CCAT2 Rs6983267 G Variant Contributes to Increased Sepsis Susceptibility in a Southern Chinese Population
por: Wu, Zhiyuan, et al.
Publicado: (2021)

Polymorphisms in lncRNA CCAT1 on the susceptibility of lung cancer in a Chinese northeast population: A case–control study
por: Ji, Yangtao, et al.
Publicado: (2022)

lncRNA involvement in hepatocellular carcinoma metastasis and prognosis
por: Abbastabar, Maryam, et al.
Publicado: (2018)

lncRNA CCAT1 Acts as a MicroRNA-218 Sponge to Increase Gefitinib Resistance in NSCLC by Targeting HOXA1
por: Jin, Xiang, et al.
Publicado: (2020)

Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells
por: Chen, Jing, et al.
Publicado: (2016)

Identification of lncRNA biomarkers in hepatocellular carcinoma by comprehensive analysis of the lncRNA-mediated ceRNA network
por: Ye, Dingde, et al.
Publicado: (2022)

Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer
por: Zhu, Liyuan, et al.
Publicado: (2019)

A five lncRNA signature for prognosis prediction in hepatocellular carcinoma
por: Sun, Yongqiang, et al.
Publicado: (2019)

LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells: LIMT contributes to sorafenib chemoresistance in HCC
por: Sun, Jing, et al.
Publicado: (2021)

lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line
por: Yang, Tianzheng, et al.
Publicado: (2018)

A Comprehensive Exploration of the lncRNA CCAT2: A Pan-Cancer Analysis Based on 33 Cancer Types and 13285 Cases
por: Huang, Bowen, et al.
Publicado: (2020)

Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge
por: Deng, Liang, et al.
Publicado: (2015)

The QKI-6 and QKI-7 RNA Binding Proteins Block Proliferation and Promote Schwann Cell Myelination
por: Larocque, Daniel, et al.
Publicado: (2009)

Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
por: Xia, Qi, et al.
Publicado: (2020)

LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma
por: Hu, Jiangfeng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gas6kacgfd0q0pec8luot476qq